Drug Shortage Report for HULIO

Last updated on 2023-01-23 History
Report ID 175244
Drug Identification Number 02502399
Brand name HULIO
Common or Proper name ADALIMUMAB
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) ADALIMUMAB
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2 x 0.8mL sterile solution (50mg/mL) subcutaneous injection (pre-filled syringe)
ATC code L04AB
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-11
Estimated end date 2023-01-18
Actual end date 2023-01-19
Shortage status Resolved
Updated date 2023-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-01-23 French Compare
v15 2023-01-23 English Compare
v14 2023-01-17 French Compare
v13 2023-01-17 English Compare
v12 2023-01-10 French Compare
v11 2023-01-10 English Compare
v10 2022-12-19 French Compare
v9 2022-12-19 English Compare
v8 2022-12-19 French Compare
v7 2022-12-19 English Compare
v6 2022-11-29 French Compare
v5 2022-11-29 English Compare
v4 2022-11-22 French Compare
v3 2022-11-22 English Compare
v2 2022-11-18 French Compare
v1 2022-11-18 English Compare

Showing 1 to 16 of 16